Influence of bone mineral density measurement on fracture risk assessment tool® scores in postmenopausal Indian women

Bhavna Daswani, Meena Desai, Sumegha Mitra, Shubhangi Gavali, Anushree Patil, Subhash Kukreja, M. Ikram Khatkhatay

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Aim: Fracture risk assessment tool® calculations can be performed with or without addition of bone mineral density; however, the impact of this addition on fracture risk assessment tool® scores has not been studied in Indian women. Given the limited availability and high cost of bone mineral density testing in India, it is important to know the influence of bone mineral density on fracture risk assessment tool® scores in Indian women. Therefore, our aim was to assess the contribution of bone mineral density in fracture risk assessment tool® outcome in Indian women. Methods: Apparently healthy postmenopausal Indian women (n = 506), aged 40–72 years, without clinical risk factors for bone disease, were retrospectively selected, and their fracture risk assessment tool® scores calculated with and without bone mineral density were compared. Results: Based on WHO criteria, 30% women were osteoporotic, 42.9% were osteopenic and 27.1% had normal bone mineral density. Fracture risk assessment tool® scores for risk of both major osteoporotic fracture and hip fracture significantly increased on including bone mineral density (P 0.0001). When criteria of National Osteoporosis Foundation, US was applied number of participants eligible for medical therapy increased upon inclusion of bone mineral density, (for major osteoporotic fracture risk number of women eligible without bone mineral density was 0 and with bone mineral density was 1, P > 0.05, whereas, for hip fracture risk number of women eligible without bone mineral density was 2 and with bone mineral density was 17, P 0.0001). Conclusion: Until the establishment of country-specific medication intervention thresholds, bone mineral density should be included while calculating fracture risk assessment tool® scores in Indian women.

Original languageEnglish (US)
Pages (from-to)20-24
Number of pages5
JournalPost reproductive health
Volume22
Issue number1
DOIs
StatePublished - Mar 1 2016
Externally publishedYes

Fingerprint

Bone Density
Osteoporotic Fractures
Hip Fractures
Bone Diseases
Osteoporosis
India
Costs and Cost Analysis

Keywords

  • Bone mineral density
  • fracture risk assessment tool®
  • India
  • osteoporosis
  • postmenopausal women

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Influence of bone mineral density measurement on fracture risk assessment tool® scores in postmenopausal Indian women. / Daswani, Bhavna; Desai, Meena; Mitra, Sumegha; Gavali, Shubhangi; Patil, Anushree; Kukreja, Subhash; Khatkhatay, M. Ikram.

In: Post reproductive health, Vol. 22, No. 1, 01.03.2016, p. 20-24.

Research output: Contribution to journalArticle

Daswani, Bhavna ; Desai, Meena ; Mitra, Sumegha ; Gavali, Shubhangi ; Patil, Anushree ; Kukreja, Subhash ; Khatkhatay, M. Ikram. / Influence of bone mineral density measurement on fracture risk assessment tool® scores in postmenopausal Indian women. In: Post reproductive health. 2016 ; Vol. 22, No. 1. pp. 20-24.
@article{ac5fa0f1e9b1458284db625d6213c93e,
title = "Influence of bone mineral density measurement on fracture risk assessment tool{\circledR} scores in postmenopausal Indian women",
abstract = "Aim: Fracture risk assessment tool{\circledR} calculations can be performed with or without addition of bone mineral density; however, the impact of this addition on fracture risk assessment tool{\circledR} scores has not been studied in Indian women. Given the limited availability and high cost of bone mineral density testing in India, it is important to know the influence of bone mineral density on fracture risk assessment tool{\circledR} scores in Indian women. Therefore, our aim was to assess the contribution of bone mineral density in fracture risk assessment tool{\circledR} outcome in Indian women. Methods: Apparently healthy postmenopausal Indian women (n = 506), aged 40–72 years, without clinical risk factors for bone disease, were retrospectively selected, and their fracture risk assessment tool{\circledR} scores calculated with and without bone mineral density were compared. Results: Based on WHO criteria, 30{\%} women were osteoporotic, 42.9{\%} were osteopenic and 27.1{\%} had normal bone mineral density. Fracture risk assessment tool{\circledR} scores for risk of both major osteoporotic fracture and hip fracture significantly increased on including bone mineral density (P 0.0001). When criteria of National Osteoporosis Foundation, US was applied number of participants eligible for medical therapy increased upon inclusion of bone mineral density, (for major osteoporotic fracture risk number of women eligible without bone mineral density was 0 and with bone mineral density was 1, P > 0.05, whereas, for hip fracture risk number of women eligible without bone mineral density was 2 and with bone mineral density was 17, P 0.0001). Conclusion: Until the establishment of country-specific medication intervention thresholds, bone mineral density should be included while calculating fracture risk assessment tool{\circledR} scores in Indian women.",
keywords = "Bone mineral density, fracture risk assessment tool{\circledR}, India, osteoporosis, postmenopausal women",
author = "Bhavna Daswani and Meena Desai and Sumegha Mitra and Shubhangi Gavali and Anushree Patil and Subhash Kukreja and Khatkhatay, {M. Ikram}",
year = "2016",
month = "3",
day = "1",
doi = "10.1177/2053369116628722",
language = "English (US)",
volume = "22",
pages = "20--24",
journal = "Post reproductive health",
issn = "2053-3691",
publisher = "Sage Publications",
number = "1",

}

TY - JOUR

T1 - Influence of bone mineral density measurement on fracture risk assessment tool® scores in postmenopausal Indian women

AU - Daswani, Bhavna

AU - Desai, Meena

AU - Mitra, Sumegha

AU - Gavali, Shubhangi

AU - Patil, Anushree

AU - Kukreja, Subhash

AU - Khatkhatay, M. Ikram

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Aim: Fracture risk assessment tool® calculations can be performed with or without addition of bone mineral density; however, the impact of this addition on fracture risk assessment tool® scores has not been studied in Indian women. Given the limited availability and high cost of bone mineral density testing in India, it is important to know the influence of bone mineral density on fracture risk assessment tool® scores in Indian women. Therefore, our aim was to assess the contribution of bone mineral density in fracture risk assessment tool® outcome in Indian women. Methods: Apparently healthy postmenopausal Indian women (n = 506), aged 40–72 years, without clinical risk factors for bone disease, were retrospectively selected, and their fracture risk assessment tool® scores calculated with and without bone mineral density were compared. Results: Based on WHO criteria, 30% women were osteoporotic, 42.9% were osteopenic and 27.1% had normal bone mineral density. Fracture risk assessment tool® scores for risk of both major osteoporotic fracture and hip fracture significantly increased on including bone mineral density (P 0.0001). When criteria of National Osteoporosis Foundation, US was applied number of participants eligible for medical therapy increased upon inclusion of bone mineral density, (for major osteoporotic fracture risk number of women eligible without bone mineral density was 0 and with bone mineral density was 1, P > 0.05, whereas, for hip fracture risk number of women eligible without bone mineral density was 2 and with bone mineral density was 17, P 0.0001). Conclusion: Until the establishment of country-specific medication intervention thresholds, bone mineral density should be included while calculating fracture risk assessment tool® scores in Indian women.

AB - Aim: Fracture risk assessment tool® calculations can be performed with or without addition of bone mineral density; however, the impact of this addition on fracture risk assessment tool® scores has not been studied in Indian women. Given the limited availability and high cost of bone mineral density testing in India, it is important to know the influence of bone mineral density on fracture risk assessment tool® scores in Indian women. Therefore, our aim was to assess the contribution of bone mineral density in fracture risk assessment tool® outcome in Indian women. Methods: Apparently healthy postmenopausal Indian women (n = 506), aged 40–72 years, without clinical risk factors for bone disease, were retrospectively selected, and their fracture risk assessment tool® scores calculated with and without bone mineral density were compared. Results: Based on WHO criteria, 30% women were osteoporotic, 42.9% were osteopenic and 27.1% had normal bone mineral density. Fracture risk assessment tool® scores for risk of both major osteoporotic fracture and hip fracture significantly increased on including bone mineral density (P 0.0001). When criteria of National Osteoporosis Foundation, US was applied number of participants eligible for medical therapy increased upon inclusion of bone mineral density, (for major osteoporotic fracture risk number of women eligible without bone mineral density was 0 and with bone mineral density was 1, P > 0.05, whereas, for hip fracture risk number of women eligible without bone mineral density was 2 and with bone mineral density was 17, P 0.0001). Conclusion: Until the establishment of country-specific medication intervention thresholds, bone mineral density should be included while calculating fracture risk assessment tool® scores in Indian women.

KW - Bone mineral density

KW - fracture risk assessment tool®

KW - India

KW - osteoporosis

KW - postmenopausal women

UR - http://www.scopus.com/inward/record.url?scp=84960114690&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960114690&partnerID=8YFLogxK

U2 - 10.1177/2053369116628722

DO - 10.1177/2053369116628722

M3 - Article

VL - 22

SP - 20

EP - 24

JO - Post reproductive health

JF - Post reproductive health

SN - 2053-3691

IS - 1

ER -